T-Cure is a clinical-stage cell and gene therapy company developing the next generation of T cell therapies against solid tumors. We are committed to bringing new oncolytic virus therapies and TCR-T therapies to patients not yet benefiting from targeted therapy or immune-checkpoint inhibitors.